Bristol-Myers Squibb Company
BMY
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in riā¦ read more
Healthcare
Drug ManufacturersāGeneral
53 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$46.65
Price-4.07%
-$1.98
1Y
Price
Market Cap
$94.968b
Large
Price/Earnings 3y Avg5y Avg
15.7x
Premium
Premium
Financials Overview
Key metrics over the past few years+37.5%
EBITDA Margin+18.0%
Net Profit Margin+49.0%
Free Cash Flow MarginRevenue
$48.034b
-0.5%
1y CAGR+1.4%
3y CAGR+1.0%
5y CAGREarnings
$6.039b
+167.5%
1y CAGR-5.7%
3y CAGR-6.7%
5y CAGREPS
$2.96
+167.1%
1y CAGR-5.4%
3y CAGR-5.4%
5y CAGRBook Value
$18.600b
$96.889b
Assets$78.289b
Liabilities$51.041b
DebtDebt to Assets
52.7%
3.4x
Debt to EBITDAFree Cash Flow
$15.302b
+9.8%
1y CAGR+8.6%
3y CAGR+1.1%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company